Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype
- 1 August 1998
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 88 (1-2) , 105-110
- https://doi.org/10.1016/s0165-5728(98)00096-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Activation of microglial cells by β-amyloid protein and interferon-γNature, 1995
- Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filamentsNature, 1994
- Increased chemiluminescence response of neutrophils from the peripheral blood of patients with senile dementia of the Alzheimer's typeJournal of Neuroimmunology, 1994
- The synaptic organization of the neocortex in Alzheimer's diseaseMedical Hypotheses, 1993
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- ?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In VitroJournal of Neurochemistry, 1993
- The role of the acute-phase protein α1-antichymotrypsin in brain dysfunction and injuryResearch in Immunology, 1992
- Developmental expression of α1-antichymotrypsin in brain may be related to astrogliosisNeurobiology of Aging, 1991
- Some morphometric aspects of the brain in senile dementia of the alzheimer typeAnnals of Neurology, 1981